Abstract
Background
Rheumatic diseases significantly affects quality of life, making self-management critical. The Illness Intrusiveness Rating Scale (IIRS) measures the extent to which illness interferes with various life domains, but until now it has not been translated into Danish.
Objective
This study aimed to translate the IIRS into Danish and assess its psychometric properties in Danish patients with a rheumatic disease.
Methods
Following COSMIN guidelines, the IIRS was translated and culturally adapted through a multi-step process, including forward and backward translations and cognitive interviews. Psychometric testing included assessments of internal construct validity by confirmatory factor analysis, internal consistency by Cronbach’s α, reliability by test–retest, standard error of measurement, and responsiveness by minimal detectable change.
Results
The final Danish version was well-understood, though minor issues arose, such as the relevance of “religious expression.” The scale demonstrated high internal consistency (Cronbach’s α = 0.92). Confirmatory factor analysis confirmed the original three-factor structure with an acceptable model fit (comparative fit index = 0.94, the Root Mean Square Error of Approximation = 0.10). Strong correlations were found within “Relationships and Personal Development” and “Instrumental” domains, but the “Diet” item did not meet factor assignment criteria. Test–retest reliability was acceptable (intraclass correlation coefficients ≥ 0.70 for most items).
Conclusion
The Danish IIRS showed strong psychometric properties, making it a reliable and valid tool for assessing illness impact and self-management interventions in Danish patients with rheumatic disease.
Key points
The scale was well-received by participants, with minimal missing data.
The Danish IIRS showed high internal consistency, acceptable test–retest reliability, and confirmed its three-factor structure.
The validated Danish IIRS is a reliable tool for assessing illness impact.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Devins, Gerald M. 2 ; Holt, Kamila 3
; Jørgensen, Jacob Brauner 1
; Esbensen, Bente Appel 4
1 Rigshospitalet, Copenhagen Center for Arthritis Research (Copecare), Copenhagen, Denmark (GRID:grid.475435.4)
2 University of Toronto, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
3 The Danish Rheumatism Association, Sano Skaelskør, Skaelskør, Denmark (GRID:grid.453380.9) (ISNI:0000 0004 4667 545X)
4 Rigshospitalet, Copenhagen Center for Arthritis Research (Copecare), Copenhagen, Denmark (GRID:grid.475435.4); Copenhagen University, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)




